Dopamine transporter genotype influences the physiological response to medication in ADHD. - Wikidata - wikimedia - TriplyDB

Dopamine transporter genotype influences the physiological response to medication in ADHD.

Dopamine transporter genotype influences the physiological response to medication in ADHD.

http://www.wikidata.org/entity/Q48506374

about

The neurobiological basis of ADHD TRDB--the Tandem Repeats Database Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa Time course analysis of motor excitability in a response inhibition task according to the level of hyperactivity and impulsivity in children with ADHD Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression.A neurogenetic approach to impulsivity Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.Motor cortex inhibition: a marker of ADHD behavior and motor development in children.Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder.Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Reward processing abnormalities in Parkinson's disease Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.Association among SNAP-25 gene DdeI and MnlI polymorphisms and hemodynamic changes during methylphenidate use: a functional near-infrared spectroscopy study.Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement Transcranial magnetic stimulation measures in attention-deficit/hyperactivity disorder.Relationship between reaction time variability and motor skill development in ADHD.Transcranial magnetic stimulation in Clinical Pharmacology Genetics of cognitive deficits in ADHD: clues for novel treatment methods.Effects of methylphenidate on motor system excitability in a response inhibition task Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.Influence of SLC6A3 and COMT variation on neural activation during response inhibition DAT by perceived MC interaction on human prefrontal activity and connectivity during emotion processing.Dopaminergic modulation of default mode network brain functional connectivity in attention deficit hyperactivity disorder.Brain plasticity and genetic factors.A current update on ADHD pharmacogenomics.Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke.Safety of Transcranial Magnetic Stimulation in Children: A Systematic Review of the Literature.Methylphenidate effects on brain activity as a function of SLC6A3 genotype and striatal dopamine transporter availability.Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.Wavelet-synchronization methodology: a new approach for EEG-based diagnosis of ADHD.SLC6A3 polymorphism and response to methylphenidate in children with ADHD: A systematic review and meta-analysis.Response Inhibition in Tic Disorders: Waiting to Respond Is Harder When ADHD Is Present.The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery Melatonin inhibits attention-deficit/hyperactivity disorder caused by atopic dermatitis-induced psychological stress in an NC/Nga atopic-like mouse model

P2860

Q24604400-9EBB18A9-DE74-4A2D-9C74-861B7B9D72C3 Q24683650-393F59E9-8FC1-4AD1-8C01-6F5B7435769F Q28486256-B97C4F1F-0F22-430C-9196-EF6C0B7B5DA4 Q30462745-D6142BD1-FE5B-4D31-B72D-F47EA009F74A Q33623531-90035C4D-A482-42D9-8B9D-5FFD5AF0AF92 Q34035619-2B85134B-1078-447F-A879-8026103D291F Q34257043-6886B7C0-4DCF-4E2E-9CF7-8F6710533AA7 Q34647141-A4FC9D45-045A-4C86-A716-030DADF36D7B Q34700914-0B6F7DF5-BBDE-4135-8454-B59DE0C0D3E1 Q34982551-D4EBE266-3D6C-4F77-8C5E-13B6C3C8FD54 Q35148556-1AF81F24-2BC9-4F7D-A5E2-98BAD0EF8E2C Q35575795-65C2E9C6-BAF4-497E-9392-89EC68ED3867 Q35587179-F9ED9053-A6DC-4FE2-8B4A-49692A15E65D Q35995076-1A56959A-AA6A-4340-BB01-2112B7927AD7 Q36162448-ABF0D252-FE2B-4F74-96E3-04637320C271 Q36287827-FA636D2B-878D-413B-BA0C-1F467D8B8C74 Q37035636-C8FEB05E-6AFA-4E16-ABFA-4296C4FE9B0E Q37139771-2A2639AF-459A-4F27-85BB-DC4AE0F7F13B Q37140825-8BB2312C-3402-447C-81BA-B70AB1CA6B03 Q37201805-0CFB1293-091D-4A2D-8968-69AEF677F87E Q37210952-89454CD6-B985-4B11-8F37-BA19F2CE9A44 Q37318439-1DFA17C5-AE34-412D-919E-D684BBC7A499 Q37514499-0EC34836-43FA-4BEE-B431-611C483458F9 Q37594329-866EEFEB-DC6F-4525-B00E-70E819A94181 Q37710514-9B995D9E-4CEC-455D-8B6E-C4E897E5BC97 Q37808658-B8FF21DB-55A6-4DA4-BF48-3CFC4BFA30F3 Q37874869-3C7755F5-6BDD-4F4B-A1F2-8828BBB622F8 Q38669324-7CE275E3-F303-42FF-874A-93D35B6174C8 Q38953059-68320FE8-9DE4-4FB7-B296-6BC793C4932D Q43100483-ADA5ED98-2A36-4850-956F-10C0B1716BE4 Q44596771-A144234C-6C39-402E-B1C0-C3C27D97F5A6 Q46002124-8E662D4A-C0C0-4CE1-9D0A-6CD53206E4C9 Q48241287-AFB6C8F8-9D76-49DB-9672-BE7145BCD956 Q48826013-F5B89679-8B48-4674-9413-5AC5100DFD40 Q57176938-1DA6950E-D1E5-41EA-AA90-F04C86D3CCAD Q57296185-4AF0718A-6873-4420-9AEF-0DE4ED5AF562

P2860

Dopamine transporter genotype influences the physiological response to medication in ADHD.

http://www.wikidata.org/entity/Q48506374

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Dopamine transporter genotype ...... esponse to medication in ADHD.

@en

Dopamine transporter genotype ...... esponse to medication in ADHD.

@nl

type

label

Dopamine transporter genotype ...... esponse to medication in ADHD.

@en

Dopamine transporter genotype ...... esponse to medication in ADHD.

@nl

prefLabel

Dopamine transporter genotype ...... esponse to medication in ADHD.

@en

Dopamine transporter genotype ...... esponse to medication in ADHD.

@nl

P1433

Q48506374-00C30A35-0858-4583-9670-AB3DA57F5B16

P1476

Q48506374-65C15A08-1890-40AB-A1D9-2B17670EA63C

P2093

Q48506374-09A15B28-15A0-4A13-A972-58ABED6E0CF5

Q48506374-0AA1E923-069D-415F-B881-35F386AEAD8B

Q48506374-3C0335B5-63FB-4350-89CC-78BBAC9A0E3E

Q48506374-3DB6816D-03DC-400D-B827-7DE337E16977

Q48506374-48FD6420-AD0A-4E53-9DAD-9F200AD9206F

Q48506374-73D7FAB3-76E6-4A7A-84AF-643027DCDCE9

Q48506374-9B832E9C-8B85-420E-BDE3-3C5E0206EE8F

Q48506374-A500CA8D-7137-4C95-92EE-8A25CAED6061

Q48506374-D7C0CE96-07EE-4444-925E-492B298B3DBC

P304

Q48506374-8C2B6C65-EDF8-46EE-A2C0-8CE51FC6A12E

P31

Q48506374-90E15ECD-857E-467B-8490-1524D64ED2FA

P356

Q48506374-66EC04AE-48AA-4988-A876-4EB369B15039

P407

Q48506374-4CCD2F92-8F77-4B56-9871-C83A3BAFA8FF

P433

Q48506374-2E56BB57-9D2F-4CA0-B94B-E7B16EF01EFA

P478

Q48506374-0747D1DF-5D81-48DA-97A8-00DCDD0FE482

P50

Q48506374-36A9CFC6-E63C-4EB5-BB66-6FB4EA150F3D

P577

Q48506374-F0AB13E9-188B-4E25-8548-F61B8B6F65F2

P5875

Q48506374-FDE2DF1D-3C28-44DC-A6E5-3B6D3A8F282F

P698

Q48506374-47DB7BF4-CA0B-4252-B98D-82DE8F6F049D

P921

Q48506374-19fb054b-e610-462e-9980-7f93c631ac22

P356

P1433

P1476

Dopamine transporter genotype ...... esponse to medication in ADHD.

@en

P2093

Colin White

http://www.w3.org/2001/XMLSchema#string

Eric M Wassermann

http://www.w3.org/2001/XMLSchema#string

Floyd R Sallee

http://www.w3.org/2001/XMLSchema#string

Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Keith R Ridel

http://www.w3.org/2001/XMLSchema#string

Nevert Badreldin

http://www.w3.org/2001/XMLSchema#string

Stephanie Merhar

http://www.w3.org/2001/XMLSchema#string

Tara D Lipps

http://www.w3.org/2001/XMLSchema#string

Zhewu Wang

http://www.w3.org/2001/XMLSchema#string

P304

2038-2046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWL147

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 8

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Donald L. Gilbert

P577

2006-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7023337

http://www.w3.org/2001/XMLSchema#string

P698

16760197

http://www.w3.org/2001/XMLSchema#string

P921